The clinical development of mupirocin
- 31 May 1990
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 22 (5) , 873-879
- https://doi.org/10.1016/0190-9622(90)70116-y
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- MUPIROCIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1987
- MUPIROCIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1987
- In-vitro activity of mupirocin (‘pseudomonic acid’) against clinical isolates of Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1985
- Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical useAntimicrobial Agents and Chemotherapy, 1985
- Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Echerichia coli by pseudomonic acidBiochemical Journal, 1978
- On the mode of action of pseudomonic acid: Inhibition of protein synthesis in Staphylococcus aureus.The Journal of Antibiotics, 1978
- Structure of pseudomonic acid, an antibiotic from Pseudomonas fluorescensJournal of the Chemical Society, Chemical Communications, 1974
- Pseudomonic Acid: an Antibiotic produced by Pseudomonas fluorescensNature, 1971